Second, existing research using extensive national US cohorts underscores a notable trend: approximately 80% of clinical encounters do not involve the use of these biomarkers for this purpose, suggesting a prevailing clinical practice pattern that often omits ESR and CRP in the bacteremia diagnostic process in the US [28]. This evidence concerns the gene ESR1 and bacterial infectious disease with sepsis.